US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

21.13

+0.22541.08%

Post-market: 21.150.0246+0.12%16:10 EST

Volume:1.32K

Turnover:27.91K

Market Cap:3.38M

PE:- -

High:21.26

Open:21.26

Low:21.13

Close:20.90

52wk High:49.22

52wk Low:19.91

Shares:160.00K

Float Shares:60.00K

Volume Ratio:0.15

T/O Rate:2.20%

Dividend:0.65

Dividend Rate:3.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

This Danish biotech's new weight-loss drug disappointed investors, and its stock is tumbling

Novo Nordisk A/S Stock Falls Friday, Outperforms Market

Novo Nordisk Targets Real-World Heart and Kidney Outcomes for Ozempic in China

Novo Resources Completes Tranche 1 Placement and Issues Cleansing Notice

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVOH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":21.1254,"timestamp":1772830800000,"preClose":20.9,"halted":0,"volume":1318,"hourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.1254,"latestTime":"16:10 EST","volume":6,"amount":126.7524,"timestamp":1772831404389,"change":0.0246,"changeRate":0.001164,"amplitude":0},"delay":0,"changeRate":0.010784688995215334,"floatShares":60000,"shares":160000,"eps":0,"marketStatus":"Market Closed","change":0.2254,"latestTime":"03-06 16:00:00 EST","open":21.26,"high":21.26,"low":21.1254,"amount":27908.501,"amplitude":0.00644,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":20.9,"aum":3427920.784371,"dividendRate":0.030967,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.15,"preClose":21.1254,"latestTime":"16:10 EST","volume":6,"amount":126.7524,"timestamp":1772831404389,"change":0.0246,"changeRate":0.001164,"amplitude":0},"volumeRatio":0.1474635809820601},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":60000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.1474635809820601,"shares":160000,"dividePrice":0.6542,"high":21.26,"amplitude":0.00644,"preClose":20.9,"low":21.1254,"week52Low":19.91,"pbRate":"--","week52High":49.2239,"institutionHeld":0,"latestPrice":21.1254,"eps":0,"divideRate":0.030967,"volume":1318,"delay":0,"ttmEps":0,"open":21.26,"prevYearClose":27.4362,"prevWeekClose":20.176,"prevMonthClose":20.176,"prevQuarterClose":27.4362,"fiveDayClose":20.176,"twentyDayClose":23.2926,"sixtyDayClose":25.8391},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617663288","title":"This Danish biotech's new weight-loss drug disappointed investors, and its stock is tumbling","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617663288?lang=en_us&edition=fundamental","pubTime":"2026-03-07 01:45","pubTimestamp":1772819100,"startTime":"0","endTime":"0","summary":"Roche, which is betting up to $5.3 billion on the Danish company, also saw its shares take a hit. Zealand Pharma is developing an amylin analog for people with overweight and obesity.Zealand Pharma's stock tumbled Friday as it sought to defend its experimental weight-loss drug after it fell short of Wall Street's expectations.Shares of the Danish drug company  tumbled 34% in European trading on Friday, and partner Roche   saw its stock fall nearly 3%.The companies, which partnered last year in a deal worth up to $5.3 billion, are developing the once-weekly injection, which is called petrelintide.On Thursday afternoon, they announced Phase 2 results from the ZUPREME-1 trial that tested the drug in 493 patients with overweight and obesity. The study met the primary endpoint, with petrelintide producing 10.7% mean weight loss against 1.7% weight loss in the placebo group. The drug had low rates of gastrointestinal side effects, a common concern for weight-loss treatments.\"This dynamic cre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995401.HKD","BK4532","IE00BZ1G4Q59.USD","LU0354030511.USD","LU1061106388.HKD","IE00BN29S564.USD","LU1069344957.HKD","LU2168563687.JPY","LU1057294990.SGD","LU2168564495.EUR","NVOX","SG9999018865.SGD","IE0005OL40V9.USD","LU1023059063.AUD","LU2461242641.AUD","BK4588","LU0672654240.SGD","LU2361044865.SGD","LU1868836757.USD","LU1280957306.USD","LLII","LU0006306889.USD","LU0316494557.USD","LLYZ","LU2168564065.EUR","LU0640476718.USD","LU0238689110.USD","LU0471298777.SGD","LU0154236417.USD","LU2468319806.SGD","LU0787776722.HKD","IE00BKVL7J92.USD","LU1814569148.SGD","LU0823434583.USD","SG9999017495.SGD","LU1983299246.USD","ZLDPF","LU2237443382.USD","IE00B1BXHZ80.USD","LU2236285917.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU0320765059.SGD","RHHBY","LU1035775433.USD","LU0385154629.USD","LU1868837136.USD","LU1974910355.USD","SG9999014914.USD","LU0234572021.USD","LU2028103732.USD","LU2746668461.USD","IE00BJJMRY28.SGD","LU2471134523.USD","LU2112291526.USD","LU1629891620.HKD","LU2237443978.SGD","LU2491050071.SGD","BK4599","LU0471298694.HKD","LU2089284900.SGD","LU2213496289.HKD","SG9999013999.USD","LU1988902786.USD","LU0256863902.USD","LU2111349929.HKD","LU0323591593.USD","LU2360106947.USD","LU0079474960.USD","LU2491049909.HKD","LU2063271972.USD","BK4139","LU2264538146.SGD","SG9999001176.USD","LU2471134952.CNY","LU1917777945.USD","LU2087625088.SGD","LU1145028129.USD","LU0943347566.SGD","LU1548497426.USD","LU2896262040.SGD","LU2237443895.HKD","SG9999015986.USD","LU0097036916.USD","LU0058720904.USD","SG9999014880.SGD","03165","LU1712237335.SGD","LU2750360641.GBP","SG9999015952.SGD","IE00BFSS7M15.SGD","LU1868836591.USD","LU2471134796.USD","IE00BWXC8680.SGD","LU2324357040.USD","LU0122379950.USD","LU2552382132.HKD","BK4534","LU0109391861.USD","LU0820562030.AUD","SG9999015945.SGD","LU2750360997.AUD","ELIS","IE00BJJMRX11.SGD","LU1804176565.USD","LU0225283273.USD","LU0114720955.EUR","LU0882574139.USD","LU0889565916.HKD","LU2237438978.USD","SGXZ31699556.SGD","LU2552382058.USD","LU0353189763.USD","IE00BFSS8Q28.SGD","LU1868837300.USD","LLYX","LU0417517546.SGD","LU1267930730.SGD","IE00B775H168.HKD","LU0094547139.USD","LU0823416689.USD","LU1291159041.SGD","IE0001KFT4U8.USD","BK4581","LU0109394709.USD","LU0266013472.USD","LU2552382215.SGD","LU1064131342.USD","LU2089283258.USD","GB00BDT5M118.USD","LU0354030438.USD","IE00BKDWB100.SGD","LU0353189680.USD","LU0203201768.USD","LU1989771016.USD","LU1868836914.USD","LU2023250330.USD","LU0964807845.USD","BK4007","IE00BJLML261.HKD","LU1720051017.SGD","LU2023251221.USD","IE00BJJMRZ35.SGD","LU2361044949.HKD","LU2168564222.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2237443622.USD","LU0256863811.USD","LU2491050154.USD","SG9999014898.SGD","SGXZ51526630.SGD","LU0320765992.SGD","LU1720051108.HKD","LU2417539215.USD","SG9999014906.USD","LU2271345857.HKD","IE00B2B36J28.USD","IE00BK4W5L77.USD","LU1093756325.SGD","ELIL","IE00BJT1NW94.SGD","LU0882574055.USD","LU0289739699.SGD","LU1323610961.USD","LU0061475181.USD","LU0466842654.USD","SG9999018857.SGD","BK4585","LU2361045086.USD","LU0786609619.USD","LU2265009873.SGD","LU2168564149.EUR","IE00BK4W5M84.HKD","LU0820561909.HKD","LU0820561818.USD","LU2756315664.SGD","LU1551013342.USD","NVOH","LU0432979614.USD","BK4516","IE0002141913.USD","SG9999001176.SGD","LU2357305700.SGD","LU1232071149.USD","LU0106261372.USD","LU0210536198.USD","SGXZ99366536.SGD","LU0203202063.USD","LU0198837287.USD","LU0823434740.USD","LU2237443465.HKD","LU0158827948.USD","LU2746668974.SGD","SGXZ81514606.USD","LU2602419157.SGD","IE00BKPKM429.USD","LU2106854487.HKD","LU0456855351.SGD","LU2237443549.SGD","LU0158827781.USD","LU1366192091.USD","IE0004445239.USD","LU2471134879.HKD","LU2756315318.SGD","SGXZ57979304.SGD","IE00B7KXQ091.USD","LU2456880835.USD","IE00B1XK9C88.USD","IE0004445015.USD","LU1127390331.HKD","LU2023250504.SGD","LU2211815571.USD","LU1623119135.USD","LU0683600562.USD","LU0689472784.USD","LU2462157665.USD","SG9999015978.USD","IE00B4JS1V06.HKD","IE0009355771.USD","LU0096364046.USD","BK4533","LU2108987350.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2617263453","title":"Novo Nordisk A/S Stock Falls Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2617263453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617263453?lang=en_us&edition=fundamental","pubTime":"2026-03-07 01:02","pubTimestamp":1772816520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slid 0.3% to DKK247.90 Friday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.0% to 2,512.42.The stock's fall  snapped a two-day winning streak.The company closed DKK374.70 short of its 52-week high of DKK622.60, which the company achieved on March 7, 2025.Trading volume was 6,430,038, compared to the 50-day average trading volume of 9,530,473.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4588","BK4007","BK4585","NVO","NVOX","BK4599","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","LU0154236417.USD","NVOH"],"gpt_icon":1},{"id":"2617631223","title":"Novo Nordisk Targets Real-World Heart and Kidney Outcomes for Ozempic in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631223","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617631223?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:32","pubTimestamp":1772814779,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Retrospective Database Study to Compare Cardiovascular and Ren...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-targets-real-world-heart-and-kidney-outcomes-for-ozempic-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-targets-real-world-heart-and-kidney-outcomes-for-ozempic-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","NVO","BK4585","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","BK4588","BK4532","NVOH","BK4007","LU0154236417.USD","LU1093756168.USD","NVOX"],"gpt_icon":0},{"id":"2617356166","title":"Novo Resources Completes Tranche 1 Placement and Issues Cleansing Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2617356166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617356166?lang=en_us&edition=fundamental","pubTime":"2026-03-06 22:09","pubTimestamp":1772806140,"startTime":"0","endTime":"0","summary":"The latest update is out from Novo Resources ( ($TSE:NVO) ). Novo Resources has completed the first tranche of a previously announced placement, is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-resources-completes-tranche-1-placement-and-issues-cleansing-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-resources-completes-tranche-1-placement-and-issues-cleansing-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4599","BK4585","NVOX","NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4007","LU0154236417.USD","LU1093756168.USD","BK4588"],"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOH\",params:#limit:6,delay:false,,,undefined,":[]}}